134 related articles for article (PubMed ID: 37028779)
1. The atypical ubiquitin ligase RNF31 stabilizes c-Myc via epigenetic inactivation of FBXO32 and promotes cancer development.
Chen Z; Ren D; Lv J; Xu Y; Xie M; He X; Shi W; Qian Q; Jing A; Ma X; Qin J; Ding Y; Geng T; Ma J; Liu W; Liu S; Ji J
Cell Signal; 2023 Jul; 107():110677. PubMed ID: 37028779
[TBL] [Abstract][Full Text] [Related]
2. FBXO32 Targets c-Myc for Proteasomal Degradation and Inhibits c-Myc Activity.
Mei Z; Zhang D; Hu B; Wang J; Shen X; Xiao W
J Biol Chem; 2015 Jun; 290(26):16202-14. PubMed ID: 25944903
[TBL] [Abstract][Full Text] [Related]
3. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z
Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319
[TBL] [Abstract][Full Text] [Related]
4. The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation.
Zhu J; Zhao C; Kharman-Biz A; Zhuang T; Jonsson P; Liang N; Williams C; Lin CY; Qiao Y; Zendehdel K; Strömblad S; Treuter E; Dahlman-Wright K
Oncogene; 2014 Aug; 33(34):4340-51. PubMed ID: 24441041
[TBL] [Abstract][Full Text] [Related]
5. DNMT1-mediated regulating on FBXO32 promotes the progression of glioma cells through the regulation of SKP1 activity.
Quan J; Ma C
Environ Toxicol; 2024 Feb; 39(2):783-793. PubMed ID: 37782699
[TBL] [Abstract][Full Text] [Related]
6. RAI14 Promotes Melanoma Progression by Regulating the FBXO32/c-MYC Pathway.
Xu J; Shi P; Xia F; Zhao X; Chen J; Geng R; Cui H; Yang L
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233342
[TBL] [Abstract][Full Text] [Related]
7. FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells.
Habel N; El-Hachem N; Soysouvanh F; Hadhiri-Bzioueche H; Giuliano S; Nguyen S; Horák P; Gay AS; Debayle D; Nottet N; Béranger G; Paillerets BB; Bertolotto C; Ballotti R
Cell Death Differ; 2021 Jun; 28(6):1837-1848. PubMed ID: 33462405
[TBL] [Abstract][Full Text] [Related]
8. LUBAC and OTULIN regulate autophagy initiation and maturation by mediating the linear ubiquitination and the stabilization of ATG13.
Chu Y; Kang Y; Yan C; Yang C; Zhang T; Huo H; Liu Y
Autophagy; 2021 Jul; 17(7):1684-1699. PubMed ID: 32543267
[TBL] [Abstract][Full Text] [Related]
9. Resonance assignments of the PUB domain of the RNF31 protein.
Song L; Zhong F; Tu X; Zhang J
Biomol NMR Assign; 2023 Dec; 17(2):189-192. PubMed ID: 37395936
[TBL] [Abstract][Full Text] [Related]
10. Endophilin-A Deficiency Induces the Foxo3a-Fbxo32 Network in the Brain and Causes Dysregulation of Autophagy and the Ubiquitin-Proteasome System.
Murdoch JD; Rostosky CM; Gowrisankaran S; Arora AS; Soukup SF; Vidal R; Capece V; Freytag S; Fischer A; Verstreken P; Bonn S; Raimundo N; Milosevic I
Cell Rep; 2016 Oct; 17(4):1071-1086. PubMed ID: 27720640
[TBL] [Abstract][Full Text] [Related]
11. Histone acetyltransferase CBP promotes function of SCF FBXL19 ubiquitin E3 ligase by acetylation and stabilization of its F-box protein subunit.
Wei J; Dong S; Yao K; Martinez MFYM; Fleisher PR; Zhao Y; Ma H; Zhao J
FASEB J; 2018 Aug; 32(8):4284-4292. PubMed ID: 29522376
[TBL] [Abstract][Full Text] [Related]
12. Ring finger protein 31-mediated atypical ubiquitination stabilizes forkhead box P3 and thereby stimulates regulatory T-cell function.
Zhu F; Yi G; Liu X; Zhu F; Zhao A; Wang A; Zhu R; Chen Z; Zhao B; Fang S; Yu X; Lin R; Liang R; Li D; Zhao W; Zhang Z; Guo W; Zhang S; Ge S; Fan X; Zhao G; Li B
J Biol Chem; 2018 Dec; 293(52):20099-20111. PubMed ID: 30389786
[TBL] [Abstract][Full Text] [Related]
13. RNF31 mediated ubiquitination of A20 aggravates inflammation and hepatocyte apoptosis through the TLR4/MyD88/NF-κB signaling pathway.
Li S; Zheng X; Hu Y; You K; Wang J
Chem Biol Interact; 2021 Oct; 348():109623. PubMed ID: 34416243
[TBL] [Abstract][Full Text] [Related]
14. FBXO32 targets PHPT1 for ubiquitination to regulate the growth of EGFR mutant lung cancer.
Zhang N; Liao Y; Lv W; Zhu S; Qiu Y; Chen N; Xiao M; Zhang H
Cell Oncol (Dordr); 2022 Apr; 45(2):293-307. PubMed ID: 35411430
[TBL] [Abstract][Full Text] [Related]
15. Atypical ubiquitin ligase RNF31: the nuclear factor modulator in breast cancer progression.
Zhu J; Zhuang T; Yang H; Li X; Liu H; Wang H
BMC Cancer; 2016 Jul; 16():538. PubMed ID: 27460922
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer.
Chou JL; Su HY; Chen LY; Liao YP; Hartman-Frey C; Lai YH; Yang HW; Deatherage DE; Kuo CT; Huang YW; Yan PS; Hsiao SH; Tai CK; Lin HJ; Davuluri RV; Chao TK; Nephew KP; Huang TH; Lai HC; Chan MW
Lab Invest; 2010 Mar; 90(3):414-25. PubMed ID: 20065949
[TBL] [Abstract][Full Text] [Related]
17. RING finger protein 31 promotes p53 degradation in breast cancer cells.
Zhu J; Zhao C; Zhuang T; Jonsson P; Sinha I; Williams C; Strömblad S; Dahlman-Wright K
Oncogene; 2016 Apr; 35(15):1955-64. PubMed ID: 26148235
[TBL] [Abstract][Full Text] [Related]
18. The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx).
Ciarapica R; De Salvo M; Carcarino E; Bracaglia G; Adesso L; Leoncini PP; Dall'Agnese A; Walters ZS; Verginelli F; De Sio L; Boldrini R; Inserra A; Bisogno G; Rosolen A; Alaggio R; Ferrari A; Collini P; Locatelli M; Stifani S; Screpanti I; Rutella S; Yu Q; Marquez VE; Shipley J; Valente S; Mai A; Miele L; Puri PL; Locatelli F; Palacios D; Rota R
Oncogene; 2014 Aug; 33(32):4173-84. PubMed ID: 24213577
[TBL] [Abstract][Full Text] [Related]
19. Smad3 Couples Pak1 With the Antihypertrophic Pathway Through the E3 Ubiquitin Ligase, Fbxo32.
Tsui H; Zi M; Wang S; Chowdhury SK; Prehar S; Liang Q; Cartwright EJ; Lei M; Liu W; Wang X
Hypertension; 2015 Dec; 66(6):1176-83. PubMed ID: 26483344
[TBL] [Abstract][Full Text] [Related]
20. Acquired platinum resistance involves epithelial to mesenchymal transition through ubiquitin ligase FBXO32 dysregulation.
Tanaka N; Kosaka T; Miyazaki Y; Mikami S; Niwa N; Otsuka Y; Minamishima YA; Mizuno R; Kikuchi E; Miyajima A; Sabe H; Okada Y; Uhlén P; Suematsu M; Oya M
JCI Insight; 2016 Nov; 1(18):e83654. PubMed ID: 27812537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
